4,200,000 Shares OCERA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 10th, 2014 • Ocera Therapeutics, Inc. • Pharmaceutical preparations • New York
Ocera Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of 4,200,000 shares (the “Firm Shares”) of the common stock, par value $0.00001 per share, of the Company (the “Common Stock”). The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 630,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares.”
